Periarticular Hyaluronic Acid in Acute Ankle Sprain
Authors:
- Robert J PetrellaRPRobert J Petrella
- Michael J PetrellaMPMichael J Petrella
- Anthony CoglianoACAnthony Cogliano
- 1 July 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Journal of Sport Medicine
- Vol. 17 (4) , 251-257
Abstract
To determine the efficacy and safety of periarticular hyaluronic acid injections in acute lateral ankle sprain during 9 months at a sports injuries center. Randomized controlled prospective trial. Primary sport medicine and emergency practice. One hundred fifty-eight consecutive competitive athletes who suffered acute grade 1 or 2 lateral ankle sprains were randomized within 48 hours of injury. Patients were randomized at baseline to periarticular injection with hyaluronic acid (HA) + standard of care [rest, ice, compression, and elevation (RICE)] or placebo injection (PL) + standard of care (RICE) treatment at baseline assessment and on day 4 after injury. Assessments at baseline and days 4, 8, 30, and 90 included Visual Analogue Scale (VAS; 0-10 cm) pain on weight bearing and walking 20 m, patient global assessment of ankle injury (five-point categorical scale), patient satisfaction with treatment (five-point categorical scale), time to return to pain-free and disability-free sport, and adverse events. Differences between groups were determined using an intent-to-treat analysis of variance. About 30% of the ankle sprains were "first" events, and no differences in clinical assessments with those presenting but not volunteering for the study (n = 341) were observed. Time to intervention was 39 +/- 4 hours, with no difference between groups. No serious adverse events were recorded during the 8-day treatment period. No difference in concomitant treatment or physical therapy was observed between groups. A significant reduction in VAS pain on both weight bearing and walking was observed at day 8 for HA compared with PL (P < 0.05). Significantly greater patient satisfaction was observed for HA versus PL at days 4 (P < 0.05), 8 (P < 0.001), 30 (P < 0.001), and 90 (P < 0.05). Patient global assessment of ankle injury was significantly better compared with baseline in the HA group at day 8, but this was not different between groups. Time to pain-free and disability-free return to sport was 11 (+/-8) versus 17 (+/-8) days for HA and PL, respectively (P < 0.05). HA treatment for acute ankle sprain was highly satisfactory in the short term and the long term versus PL. This was associated with reduced pain and more rapid return to sport, with few associated adverse events.Keywords
This publication has 14 references indexed in Scilit:
- Financial cost of osteoarthritis in FranceJoint Bone Spine, 2005
- Topical Ketoprofen Patch (100 mg) for the Treatment of Ankle Sprain: A Randomized, Double-Blind, Placebo-Controlled StudyThe American Journal of Sports Medicine, 2005
- Efficacy of Celecoxib, a COX-2–Specific Inhibitor, and Naproxen in the Management of Acute Ankle SprainClinical Journal of Sport Medicine, 2004
- Population based epidemiology of ankle sprains attending accident and emergency units in the West Midlands of England, and a survey of UK practice for severe ankle sprainsEmergency Medicine Journal, 2003
- Prospective validation of clinically important changes in pain severity measured on a visual analog scaleAnnals of Emergency Medicine, 2001
- Immobilisation for acute ankle sprainArchives of orthopaedic and trauma surgery, 2001
- Viscosupplementation effect on proprioception in the osteoarthritic kneeArchives of Physical Medicine and Rehabilitation, 2000
- The number needed to treat: a clinically useful measure of treatment effectBMJ, 1995
- An epidemiological survey on ankle sprain.British Journal of Sports Medicine, 1994
- Piroxicam in acute musculoskeletal disorders and sports injuriesThe American Journal of Medicine, 1988